Bausch + Lomb Financial Ratios
NYSE: BLCOHealth CareOphthalmic GoodsUSD
17.30+0.15 (+0.87%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bausch + Lomb ratio analysis
Bausch + Lomb earned a net margin of -7.1% in FY 2025, down from -6.6% a year earlier. Return on equity reached -5.6%, meaning Bausch + Lomb generated -0.06 dollars of profit for every dollar of shareholders' equity. Debt-to-equity stood at 0.78 versus 0.74 the year before, and the current ratio was 1.55.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Bausch + Lomb financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | — | — | 775.50 | — | — |
| Price / sales | 1.15 | 1.30 | 1.44 | 1.44 | — | — |
| Price / book | 0.91 | 0.96 | 0.87 | 0.77 | — | — |
| Operating margin | 2.2% | 3.4% | 3.1% | 5.5% | 8.7% | 7.6% |
| Net margin | -7.1% | -6.6% | -6.3% | 0.2% | 4.8% | -0.5% |
| Free cash flow margin | -1.3% | -1.2% | -4.8% | 4.5% | 18.1% | 7.9% |
| Return on equity (ROE) | -5.6% | -4.9% | -3.8% | 0.1% | 2.0% | -0.2% |
| Return on assets (ROA) | -2.6% | -2.4% | -1.9% | 0.1% | 1.7% | — |
| Debt / equity | 0.78 | 0.74 | 0.67 | 0.35 | 0.00 | — |
| Current ratio | 1.55 | 1.60 | 1.74 | 1.65 | 1.49 | — |
| Revenue growth | 6.5% | 15.6% | 10.0% | 0.1% | 10.3% | — |
| EPS growth | — | — | -3,800.0% | -96.2% | — | — |